Atrium Therapeutics Inc (RNA)

Cost of Revenue

$494.00K

TTM · Period ending: · USD

RNA logo

RNA Cost of Revenue

Latest reported$494.00K
RNA TTM Cost of Revenue ($494.00K → $494.00K)
More history is needed to export this chart.

RNA cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Atrium Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
494,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.